Comprehensive Medical Weight Loss
There is exciting news for all of our Type 2 Diabetics. Bydureon has now been approved for the treatment of Type 2 Diabetes. When patients are not controlled on metformin or metformin plus a sulfonylurea (Glipizide / Glucotrol) or thiazoladinedione…
On February 22nd, 2012, the Advisory Committee to the FDA met to review a new weight loss drug, Qnexa. This drug is a combination of Phentermine and Topiramate, and the combination yields substantially better weight loss than Phentermine alone, even…
The American Medical Association “AMA Weigh What Matters” app is a great new tool provided for free! It makes it easy to work with your Physician or Registered Dietitian to establish weight, healthy eating, and physical activity goals, and track…
For our health care workers out there, Dr. Lazarus is honored to have been invited again to participate in Grand Rounds. This year, the title of my talk is: Obesity Medicine Why telling an individual to “Eat Less, Exercise More”…
Wow, it’s already mid-January! We can now truly say that we survived the holiday stuffing (turkey, ourselves, our friends?) and all of the New Year’s goodies. Are you already into this year’s remaking, re-fitting and re-planning? What are your health…
Most individuals that I meet at CNC come in highly motivated and proceed to accomplish their weight loss goals. Unfortunately, sometimes in the months and years that follow this level of motivation wanes, some weight is regained, and the end…
It is well established that certain types of foods can cause disease. Excess salt can elevate blood pressure and excess trans-fats can contribute to early heart disease. Have you considered that we can use foods to cure disease? In addition…
Many individuals take New Years as a time to seriously reconsider their health. In fact, over the next several weeks, I expect to meet many new patients in the office with the goal of losing 50 or more pounds. If…
[pro-player width=”560″ height=”315″][/pro-player]
The FDA is again considering approval of an experimental weight loss drug it rejected a year ago over concerns about potential heart problems and birth defects in babies born to women who take the drug. California-based pharmaceutical company Vivus…
